2025 Speakers

Pharma Thought Leaders

Alberto Calabro

Patient Access Program & Supply Lead

Roche

Annie Drelles

Senior Director - Medical Access, Global Oncology Medical Affairs

Daiichi Sankyo

Antoine Robert

Global Post-Trial Access Lead

Sanofi

Ben Rotz

Associate Vice President - Global Medical Policy Strategy & Operations

Eli Lilly & Co.

Cassandra Slader

Global Head of MAP

UCB

Catherine Singfield

Senior Director, Head of Medical Affairs Operations, Planning, Integration, Evidence Optimisation & Managed Access Programmes Te

Jazz Pharmaceuticals

Helen Dean

Associate Director - Medical Affairs International Operations & Planning

Jazz Pharmaceuticals

Katy Mulleady

Director - Pre-Approval Access Operations

Abbvie

Lesley Perkin

Patient Advocacy Lead

UCB

Lisa Seifert

Distribution Process Expert

Boehringer Ingelheim

Maja Galic

Head of Global Medical Affairs Operations & Excellence

Teva Pharmaceuticals

Martina Vanek

Trial Manager for Special Programmes

Boehringer Ingelheim

Nicola GIllott

Global Head of Expanded Access

Chiesi

Olga Andreeva

Global Medical Excellence Director

Novo Nordisk

Rachel Harrison

Director - Preapproval, Post Trial Access Programs, Medical Affairs & Evidence Generation

Argenx

Ramona Reichenbach

Head of Managed Access Center of Excellence

Novartis

Simon Morgan

Team Lead

Pfizer

Zoe Zeliku

Associate Director, Clinical Development, Value Evidence & Outcomes, Oncology

GSK

Biotech Thought Leaders

Bethany Bearden, Blueprint Bio, 3rd Operationalise: Early Access Programmes Europe 2024

Bethany Bearden

Associate Director - Early Access Program Operations

Blueprint Medicines

Chiara Troncatti

Head, Business Operations, EMEA

Avidity Biosciences

Karen Frascello

Senior Director - Medical Affairs

Alnylam Pharmaceuticals

Kjersten Teeter

Director, Head of Medical Affairs Operations

Blueprint Medicines

Mallory Fredericks

Associate Director - Global Patient Access

SpringWorks Therapeutics

Michael Hotze

Director Medical Affairs

Incyte

Michela Pantaleoni

Chief Market Access Officer

Napo Therapeutics

Natalia Kashtalian

Senior Medical Excellence Manager

Sobi

Sarah Moore

Director

ImmunoGen Switzerland GmbH (now a part of AbbVie)

Suzanne webster

Head of International Patient Services

Sarepta Therapeutics

Suzanne Webster

Head of International Patient Services

Sarepta Therapeutics

Tamara Popov

Global Medical Lead Rare Nephrology

Vifor Pharma

Patient & Advocacy Voices

Chris Hendriksz

Chief Community Impact Officer

A Rare Cause

Harpreet Ram

Principal

GARDaccess

Lucy & Mike Carroll

Parents to Ollie & Amelia Living with Battens Disease

Tanya Collin-Histed

CEO

International Gaucher Alliance

Trusted Partners

Ana Tediosi

Director & Head of Expanded Access Program Strategy & Business Development

WEP Clinical

Anne Cropp

Chief Scientific Officer

Early Access Care

Catherine Parry

Senior commercial manager

BAP Pharma Ltd.

Dennis Akkaya

Chief Commercial Officer (Cco)

myTomorrows

Harry Martin

Porfolio Director

Bionical Emas

Karlijn Doorn

Head of Operations

myTomorrows

Katie Bowen

Project Manager, Medicines Access

BAP Pharma Ltd.

Naomi Litchfield

Director, Patient Advocacy

Bionical Emas

Paul Stanton

Senior Director, Global Strategy

Inceptua

Sarah Alummootil

Associate Director - Early Access Programs

Early Access Care

Stephanie Ferket

Director, Expanded Access Strategy & Customer Success

myTomorrows